Sunday, December 29, 2024

Marc ZERBOLA CHALLANDE

172 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Bright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.  On September 25th, the company will host an event to...

Rising Uranium Demand: Why Premier American Uranium is Poised for Success

Premier American Uranium holds significant land in key U.S. uranium regions, essential for reducing reliance on foreign uranium sources. Recent exploration at the Cyclone ISR...

The Race for U.S. Lithium Independence in the EV Revolution

Lithium demand is projected to quadruple by 2030, driven by the electric vehicle boom and increasing global energy storage needs. Li-FT Power has strengthened its...

The Future of Cancer Therapy is Here

RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy. With a projected 330% price increase, RenovoRx is gaining investor...

Investing in Biotech: Why 2024 Could Be the Year of Major Gains

2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector. Gene therapy and oncology are driving biotech...

Breaking

Holiday Financial Cheer: Navigating the Season with Savvy Investments

As the holiday season wraps the world in its...

5 Quantum Computing Stocks to Look After

Quantum computing is rapidly emerging as one of the...

Quantum Computing Skyrocketed, Who’s Next? 

Quantum Computing Inc. (QUBT) has taken the market by...

APRE vs. KPTI: Which Stock is the Best Choice? 

Aprea Therapeutics, Inc. (NASDAQ: APRE) and Karyopharm Therapeutics Inc....
spot_img